Suppliers

Probiota Day 1: First 1,000 Days & Skin Health

Probiota Day 1: First 1,000 Days & Skin Health

By Stephen Daniells

With just five weeks to go before the start of Probiota in Milan, NutraIngredients previews what attendees can expect each day of this three-day microbiome extravaganza.

© vovashevchuk / Getty Images

ImperialOel on innovating within a shifting omega-3 market

By Olivia Brown

The natural lipid ingredient and supplement supplier ImperialOel l says the omega-3 market is in a transition phase due to high prices and severe fish oil shortages, creating a strong demand for sustainable alternatives to meet the health needs of the...

© asikkk / Getty Images

Guest Article

Omega-3 Market Update: It’s All About the Supply

By Ellen Schutt, Managing Director, GOED

To sum up the discussions about the EPA and DHA omega-3 market in 2023, only one word is required: “supply.” The focus of just about every conversation during the past year has been concern about the supply of fish oil, specifically from the Peruvian...

Copyright: Marilyna | Getty Images

Time for a smarter approach to adaptogens

By Nikki Hancocks

Nektium scientists are working to better educate on the benefits of adaptogenic ingredients and improve classification, with a focus on two of the "hero" ingredients of this realm: Rhodiola rosea (RR) and Withania somnifera (WS).

© vovashevchuk / Getty Images

GC Rieber: Innovating for optimal omega-3 oils

By Olivia Brown

The omega-3 oils producer VivoMega by GC Rieber has introduced its innovation VivoSens, which enables for the optimisation of the sensory analysis and subsequent performance of omega-3 oils.

Sebastian Balcombe talks of the liposomal technology created by Specnova, the company he founded.

Specnova’s Sebastian Balcombe on advances in liposomal technology

By Claudia Adrien

Liposomes are delivery vehicles for transporting substances into the body, and they are Sebastian Balcombe’s forte. Balcombe, founder and CEO of biotechnology company Specnova, spoke with NutraIngredients-USA at this year’s SupplySide West about the advances...

© Madeleine_Steinbach / Getty Images

Aker BioMarine acquires IP & equipment from Acasti Pharma Inc.

By Stephen Daniells

Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc.

Follow us

Products

View more

Webinars